Development and Plasticity Section, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA.
Restor Neurol Neurosci. 2010;28(4):589-603. doi: 10.3233/RNN-2010-0543.
The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate specialized cells to replace damaged tissue in patients suffering from various degenerative diseases. However, the signaling mechanisms involved in lineage restriction of ESC to adopt various cellular phenotypes are still under investigation. Furthermore, for progression of hESC-based therapies towards clinical applications, appropriate culture conditions must be developed to generate genetically stable homogenous populations of cells, to hinder possible adverse effects following transplantation. Other critical challenges that must be addressed for successful cell implantation include problems related to survival and functional efficacy of the grafted cells. This review initially describes the derivation of hESC and focuses on recent advances in generation, characterization, and maintenance of these cells. We also give an overview of original and emerging differentiation strategies used to convert hESC to different cell types. Finally, we will discuss transplantation studies of hESC-derived cells with respect to safety and functional recovery.
人类胚胎干细胞(hESC)最大的治疗潜力是产生专门的细胞,以替代患有各种退行性疾病的患者受损的组织。然而,涉及 ESC 谱系限制以采用各种细胞表型的信号机制仍在研究中。此外,为了将基于 hESC 的治疗方法推进到临床应用,必须开发适当的培养条件,以产生遗传稳定的同质细胞群体,以阻止移植后可能出现的不良反应。成功进行细胞移植必须解决的其他关键挑战包括与移植细胞的存活和功能功效相关的问题。本文首先描述了 hESC 的衍生,并重点介绍了这些细胞的生成、表征和维持方面的最新进展。我们还概述了用于将 hESC 转化为不同细胞类型的原始和新兴分化策略。最后,我们将讨论 hESC 衍生细胞的移植研究,重点是安全性和功能恢复。